Shattuck Labs (STTK)
(Real Time Quote from BATS)
$4.47 USD
+0.16 (3.71%)
Updated Jul 25, 2024 02:47 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Price, Consensus and EPS Surprise
STTK 4.47 +0.16(3.71%)
Will STTK be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for STTK based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for STTK
Kymera Therapeutics (KYMR) Surges 23.4%: Is This an Indication of Further Gains?
Shattuck (STTK) Announces Positive Interim Data on Cancer Drug
STTK: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging -19.89% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK)
What Makes Shattuck Labs (STTK) a New Buy Stock
Does Shattuck Labs (STTK) Have the Potential to Rally 34.17% as Wall Street Analysts Expect?
Other News for STTK
Catalyst Watch: Tesla deliveries, Constellation Brands earnings, and the June Jobs Report
Video: Thursday 6/27 Insider Buying Report: STTK, INMB
Workday To Rally Over 52%? Here Are 10 Top Analyst Forecasts For Thursday
Shattuck Labs price target lowered by $12 at H.C. Wainwright, here's why
Hold For Now: Shattuck Labs' SL-172154 Potential In Early Trials